Parametric Portfolio Associates LLC grew its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 23.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,893,195 shares of the pharmacy operator’s stock after purchasing an additional 549,575 shares during the quarter. Parametric Portfolio Associates LLC owned approximately 0.32% of Walgreens Boots Alliance worth $158,171,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in WBA. Caisse DE Depot ET Placement DU Quebec boosted its holdings in shares of Walgreens Boots Alliance by 11.0% in the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,837,465 shares of the pharmacy operator’s stock valued at $647,154,000 after buying an additional 1,169,600 shares in the last quarter. LSV Asset Management boosted its position in shares of Walgreens Boots Alliance by 0.9% in the 1st quarter. LSV Asset Management now owns 11,672,531 shares of the pharmacy operator’s stock valued at $738,521,000 after purchasing an additional 107,600 shares during the period. Northern Trust Corp boosted its position in shares of Walgreens Boots Alliance by 0.7% in the 2nd quarter. Northern Trust Corp now owns 11,647,146 shares of the pharmacy operator’s stock valued at $636,750,000 after purchasing an additional 76,864 shares during the period. Geode Capital Management LLC grew its stake in Walgreens Boots Alliance by 7.8% during the 4th quarter. Geode Capital Management LLC now owns 11,529,136 shares of the pharmacy operator’s stock worth $786,522,000 after buying an additional 834,241 shares during the last quarter. Finally, Nordea Investment Management AB grew its stake in Walgreens Boots Alliance by 2.0% during the 1st quarter. Nordea Investment Management AB now owns 7,679,640 shares of the pharmacy operator’s stock worth $485,896,000 after buying an additional 148,814 shares during the last quarter. Institutional investors and hedge funds own 59.80% of the company’s stock.
Shares of NASDAQ WBA traded up $0.98 on Wednesday, hitting $57.86. The company had a trading volume of 409,077 shares, compared to its average volume of 4,385,283. The company has a quick ratio of 0.37, a current ratio of 0.76 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance Inc has a 12-month low of $49.03 and a 12-month high of $86.31. The business has a 50 day moving average of $52.26 and a two-hundred day moving average of $55.21. The firm has a market capitalization of $50.21 billion, a P/E ratio of 9.58, a PEG ratio of 1.39 and a beta of 0.88.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.42 by $0.05. The company had revenue of $34.59 billion during the quarter, compared to analysts’ expectations of $34.52 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The business’s revenue was up .7% on a year-over-year basis. During the same period in the prior year, the business posted $1.53 EPS. On average, sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 5.98 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Tuesday, August 20th will be issued a $0.458 dividend. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. The ex-dividend date is Monday, August 19th. This represents a $1.83 annualized dividend and a dividend yield of 3.17%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 30.40%.
In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total value of $10,869,505.04. Following the sale, the chief accounting officer now directly owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 15.73% of the company’s stock.
WBA has been the subject of a number of research reports. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Wednesday. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price objective for the company. in a report on Monday, June 10th. Bank of America lowered their target price on shares of Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating on the stock in a research report on Monday, June 3rd. JPMorgan Chase & Co. cut their target price on shares of Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a report on Friday, June 28th. Finally, ValuEngine upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, June 28th. Six analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the company’s stock. Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus price target of $63.65.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Further Reading: How is Preferred Stock Different from Common Stock?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.